Júlia Oto
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
-
- Renal cell carcinoma treatment 3
- Co-authors
- Pilar Medina (30 shared papers)Álvaro Fernández‐Pardo (18 shared papers)Emma Plana (19 shared papers)Francisco España (13 shared papers)Silvia Navarro (11 shared papers)C.D. Vera Donoso (12 shared papers)David Hervás (9 shared papers)Manuel Miralles (5 shared papers)
In The Last Decade
Júlia Oto
29 papers receiving 420 citations
Peers
Comparison fields: 5 of 74
- Internal Medicine 31
- Cancer Research 100
- Immunology 112
- Immunology and Allergy 24
- Hematology 34
Countries citing papers authored by Júlia Oto
This map shows the geographic impact of Júlia Oto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Júlia Oto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Júlia Oto more than expected).
Fields of papers citing papers by Júlia Oto
This network shows the impact of papers produced by Júlia Oto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Júlia Oto. The network helps show where Júlia Oto may publish in the future.
Co-authors
The 25 scholars most cited alongside Júlia Oto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 34 | |
| 2 | 2020 | 33 | |
| 3 | 2023 | 32 | |
| 4 | 2020 | 32 | |
| 5 | 2023 | 29 | |
| 6 | 2020 | 29 | |
| 7 | 2020 | 29 | |
| 8 | 2020 | 25 | |
| 9 | 2020 | 24 | |
| 10 | 2020 | 21 | |
| 11 | 2019 | 19 | |
| 12 | 2023 | 18 | |
| 13 | 2021 | 15 | |
| 14 | 2018 | 13 | |
| 15 | 2022 | 12 | |
| 16 | 2021 | 12 | |
| 17 | 2023 | 7 | |
| 18 | 2022 | 7 | |
| 19 | 2020 | 6 | |
| 20 | 2022 | 5 |
About Júlia Oto
Júlia Oto is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Immunology, having authored 32 papers that have together received 423 indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Cancer-related molecular mechanisms research (4 papers), Renal cell carcinoma treatment (3 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Internal Medicine (31 citations), Cancer Research (100 citations), Immunology (112 citations), Immunology and Allergy (24 citations) and Hematology (34 citations). Júlia Oto has collaborated with scholars based in Spain, Germany and Belgium. Frequent co-authors include Pilar Medina, Álvaro Fernández‐Pardo, Emma Plana, Francisco España, Silvia Navarro, C.D. Vera Donoso, David Hervás, Manuel Miralles, Luis Ramón and Josep Marí‐Alexandre. Their work appears in journals such as International Journal of Molecular Sciences, Cancers, Frontiers in Immunology, Journal of Proteomics and Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.